{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:02:16Z","timestamp":1791525736189,"version":"4.3.4"},"reference-count":41,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.3201\/eid3011.240610","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T14:04:06Z","timestamp":1729692246000},"source":"Crossref","is-referenced-by-count":6,"title":["Risk for Facial Palsy after COVID-19 Vaccination, South Korea, 2021\u20132022"],"prefix":"10.3201","volume":"30","author":[{"given":"Dongwon","family":"Yoon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyungyeon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwa Yeon","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Byeol-A","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ju-Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"CoVaSC Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid3011.240610-202410081656-R1","unstructured":"Wollersheim S. US Food and Drug Administration. Vaccines and Related Biological Products Advisory Committee meeting: FDA review of efficacy and safety of Pfizer-BioNTech COVID-19 vaccine emergency use authorization request [cited 2023 Sep 1]. https:\/\/www.fda.gov\/media\/144337\/download"},{"key":"key-10.3201\/eid3011.240610-202410081656-R2","unstructured":"US Food and Drug Administration. Vaccines and Related Biological Products Advisory Committee meeting presentation: FDA review of efficacy and safety of Moderna COVID-19 vaccine emergency use authorization request [cited 2023 Sep 1]. https:\/\/www.fda.gov\/media\/144585\/download"},{"key":"key-10.3201\/eid3011.240610-202410081656-R3","doi-asserted-by":"publisher","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid3011.240610-202410081656-R4","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1056\/NEJMoa2113017","article-title":"Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase.","volume":"385","author":"El Sahly","year":"2021","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid3011.240610-202410081656-R5","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1056\/NEJMoa2105290","article-title":"AstraZeneca AZD1222 Clinical Study Group. Phase 3 safety and efficacy of AZD1222 (ChAdOx1 nCoV-19) Covid-19 vaccine.","volume":"385","author":"Falsey","year":"2021","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid3011.240610-202410081656-R6","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1056\/NEJMoa2117608","article-title":"Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.S.","volume":"386","author":"Sadoff","year":"2022","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid3011.240610-202410081656-R7","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1136\/jnnp-2014-309563","article-title":"Bell\u2019s palsy: aetiology, clinical features and multidisciplinary care.","volume":"86","author":"Eviston","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key-10.3201\/eid3011.240610-202410081656-R8","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell\u2019s palsy in Switzerland.","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid3011.240610-202410081656-R9","unstructured":"Law B. Safety Platform for Emergency vACcines (SPEAC) Project: SO2-D2.1.2 priority list of COVID-19 adverse events of special interest: quarterly update December 2020. Oslo, Norway: Coalition for Epidemic Preparedness Innovations; 2020."},{"key":"key-10.3201\/eid3011.240610-202410081656-R10","doi-asserted-by":"publisher","first-page":"e291","DOI":"10.1093\/cid\/ciac460","article-title":"Messenger RNA coronavirus disease 2019 (COVID-19) vaccination with BNT162b2 increased risk of Bell\u2019s palsy: a nested case-control and self-controlled case series study.","volume":"76","author":"Wan","year":"2023","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid3011.240610-202410081656-R11","doi-asserted-by":"publisher","first-page":"100236","DOI":"10.1016\/j.lanepe.2021.100236","article-title":"Association between vaccination with the BNT162b2 mRNA COVID-19 vaccine and Bell\u2019s palsy: a population-based study.","volume":"11","author":"Shibli","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"key-10.3201\/eid3011.240610-202410081656-R12","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1007\/s13760-023-02245-7","article-title":"Risk and characteristics of Bell\u2019s palsy in adults as an adverse event following COVID-19 vaccination: a retrospective study.","volume":"123","author":"Kim","year":"2023","journal-title":"Acta Neurol Belg"},{"key":"key-10.3201\/eid3011.240610-202410081656-R13","doi-asserted-by":"publisher","first-page":"e068373","DOI":"10.1136\/bmj-2021-068373","article-title":"Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis.","volume":"376","author":"Li","year":"2022","journal-title":"BMJ"},{"key":"key-10.3201\/eid3011.240610-202410081656-R14","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1038\/s41591-021-01556-7","article-title":"Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection.","volume":"27","author":"Patone","year":"2021","journal-title":"Nat Med"},{"key":"key-10.3201\/eid3011.240610-202410081656-R15","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1001\/jamaoto.2023.0160","article-title":"Association of SARS-CoV-2 vaccination or infection with Bell palsy: a systematic review and meta-analysis.","volume":"149","author":"Rafati","year":"2023","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"key-10.3201\/eid3011.240610-202410081656-R16","doi-asserted-by":"publisher","first-page":"85","DOI":"10.47176\/mjiri.36.85","article-title":"Bell\u2019s palsy and COVID-19 vaccination: a systematic review.","volume":"36","author":"Shahsavarinia","year":"2022","journal-title":"Med J Islam Repub Iran"},{"key":"key-10.3201\/eid3011.240610-202410081656-R17","doi-asserted-by":"publisher","first-page":"e351","DOI":"10.3346\/jkms.2022.37.e351","article-title":"COVID-19 vaccination in Korea: past, present, and the way forward.","volume":"37","author":"Nham","year":"2022","journal-title":"J Korean Med Sci"},{"key":"key-10.3201\/eid3011.240610-202410081656-R18","doi-asserted-by":"publisher","first-page":"i4515","DOI":"10.1136\/bmj.i4515","article-title":"Self controlled case series methods: an alternative to standard epidemiological study designs.","volume":"354","author":"Petersen","year":"2016","journal-title":"BMJ"},{"key":"key-10.3201\/eid3011.240610-202410081656-R19","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.1016\/j.vaccine.2022.06.010","article-title":"Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platform.","volume":"40","author":"Walker","year":"2022","journal-title":"Vaccine"},{"key":"key-10.3201\/eid3011.240610-202410081656-R20","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/S0140-6736(20)31208-3","article-title":"Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.","volume":"395","author":"Zhu","year":"2020","journal-title":"Lancet"},{"key":"key-10.3201\/eid3011.240610-202410081656-R21","doi-asserted-by":"publisher","first-page":"101529","DOI":"10.1016\/j.eclinm.2022.101529","article-title":"Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S\/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study.","volume":"50","author":"Garc\u00eda-P\u00e9rez","year":"2022","journal-title":"EClinicalMedicine"},{"key":"key-10.3201\/eid3011.240610-202410081656-R22","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing.","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"key-10.3201\/eid3011.240610-202410081656-R23","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1001\/jamaoto.2021.1266","article-title":"Incidence of Bell palsy in patients with COVID-19.","volume":"147","author":"Tamaki","year":"2021","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"key-10.3201\/eid3011.240610-202410081656-R24","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1016\/j.cmi.2023.08.014","article-title":"Risk of Bell\u2019s palsy following SARS-CoV-2 infection: a nationwide cohort study.","volume":"29","author":"Kim","year":"2023","journal-title":"Clin Microbiol Infect"},{"key":"key-10.3201\/eid3011.240610-202410081656-R25","doi-asserted-by":"publisher","first-page":"e887","DOI":"10.1002\/hsr2.887","article-title":"Facial palsy as a manifestation of COVID-19: A systematic review of cases.","volume":"5","author":"Khurshid","year":"2022","journal-title":"Health Sci Rep"},{"key":"key-10.3201\/eid3011.240610-202410081656-R26","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s12026-023-09357-5","article-title":"COVID-19 vaccines adverse events: potential molecular mechanisms.","volume":"71","author":"Lamprinou","year":"2023","journal-title":"Immunol Res"},{"key":"key-10.3201\/eid3011.240610-202410081656-R27","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/S1473-3099(21)00076-1","article-title":"Bell\u2019s palsy and SARS-CoV-2 vaccines.","volume":"21","author":"Ozonoff","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid3011.240610-202410081656-R28","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1038\/s12276-023-01086-x","article-title":"Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics.","volume":"55","author":"Lee","year":"2023","journal-title":"Exp Mol Med"},{"key":"key-10.3201\/eid3011.240610-202410081656-R29","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.therap.2021.03.005","article-title":"Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell\u2019s palsy.","volume":"76","author":"Soeiro","year":"2021","journal-title":"Therapie"},{"key":"key-10.3201\/eid3011.240610-202410081656-R30","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3389\/fpubh.2020.00361","article-title":"Do vaccines have a role as a cause of autoimmune neurological syndromes?","volume":"8","author":"Principi","year":"2020","journal-title":"Front Public Health"},{"key":"key-10.3201\/eid3011.240610-202410081656-R31","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.3109\/00016489109100758","article-title":"The HLA system and T-cell subsets in Bell\u2019s palsy.","volume":"111","author":"Gorodezky","year":"1991","journal-title":"Acta Otolaryngol"},{"key":"key-10.3201\/eid3011.240610-202410081656-R32","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1365-2273.1987.tb00203.x","article-title":"Cellular immunity abnormalities in patients with recurrent Bell\u2019s palsy.","volume":"12","author":"Ma\u00f1\u00f3s-Pujol","year":"1987","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"key-10.3201\/eid3011.240610-202410081656-R33","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1023\/B:DDAS.0000026389.56819.0c","article-title":"Bell\u2019s palsy: a rare complication of interferon therapy for hepatitis C.","volume":"49","author":"Hwang","year":"2004","journal-title":"Dig Dis Sci"},{"key":"key-10.3201\/eid3011.240610-202410081656-R34","doi-asserted-by":"publisher","first-page":"245","DOI":"10.12688\/f1000research.2-245.v1","article-title":"Bell\u2019s palsy during interferon alpha 2a treatment in a case with Beh\u00e7et uveitis.","volume":"2","author":"Yal\u00e7inda\u011f","year":"2013","journal-title":"F1000Res"},{"key":"key-10.3201\/eid3011.240610-202410081656-R35","doi-asserted-by":"publisher","first-page":"4666","DOI":"10.1016\/j.vaccine.2023.06.014","article-title":"Evaluation of potential adverse events following COVID-19 mRNA vaccination among adults aged 65 years and older: Two self-controlled studies in the U.S.","volume":"41","author":"Shoaibi","year":"2023","journal-title":"Vaccine"},{"key":"key-10.3201\/eid3011.240610-202410081656-R36","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1128\/CMR.19.1.80-94.2006","article-title":"Molecular mimicry, bystander activation, or viral persistence: infections and autoimmune disease.","volume":"19","author":"Fujinami","year":"2006","journal-title":"Clin Microbiol Rev"},{"key":"key-10.3201\/eid3011.240610-202410081656-R37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0316-1","article-title":"The activation of bystander CD8+ T cells and their roles in viral infection.","volume":"51","author":"Kim","year":"2019","journal-title":"Exp Mol Med"},{"key":"key-10.3201\/eid3011.240610-202410081656-R38","doi-asserted-by":"publisher","first-page":"100091","DOI":"10.1016\/j.jacig.2023.100091","article-title":"Differential T-cell and antibody responses induced by mRNA versus adenoviral vectored COVID-19 vaccines in patients with immunodeficiencies.","volume":"2","author":"Aguinam","year":"2023","journal-title":"J Allergy Clin Immunol Glob"},{"key":"key-10.3201\/eid3011.240610-202410081656-R39","first-page":"S1","article-title":"Clinical practice guideline: Bell\u2019s palsy.","volume":"149","author":"Baugh","year":"2013","journal-title":"Otolaryngol Head Neck Surg"},{"key":"key-10.3201\/eid3011.240610-202410081656-R40","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1002\/mus.27213","article-title":"Epidemiological trends of Bell\u2019s palsy treated with steroids in Korea between 2008 and 2018.","volume":"63","author":"Lee","year":"2021","journal-title":"Muscle Nerve"},{"key":"key-10.3201\/eid3011.240610-202410081656-R41","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.vaccine.2016.05.023","article-title":"Facial nerve palsy including Bell\u2019s palsy: Case definitions and guidelines for collection, analysis, and presentation of immunisation safety data.","volume":"35","author":"Rath","year":"2017","journal-title":"Vaccine"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/30\/11\/24-0610_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T18:36:50Z","timestamp":1732905410000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/30\/11\/24-0610_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"URL":"https:\/\/doi.org\/10.3201\/eid3011.240610","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11]]}}}